The Diabetes Update programme is an initiative for trainees in diabetes and endocrinology. It aims to cover the diabetes section of the training curriculum for diabetes and endocrinology issued by the Joint Royal Colleges of Physicians Training Board. It is also a great opportunity for more established clinicians to find out the latest updates in the area of diabetes.

The Diabetes Update programme is an initiative for trainees in diabetes and endocrinology. It aims to cover the diabetes section of the training curriculum for diabetes and endocrinology issued by the Joint Royal Colleges of Physicians Training Board. It is also a great opportunity for more established clinicians to find out the latest updates in the area of diabetes.

REGISTRATION FOR ABCD DIABETES UPDATE 2024 IS NOW CLOSED!

31st January - 2nd February 2024.

The Diabetes Update programme is a new initiative for trainees in diabetes and endocrinology. It aims to cover the diabetes section of the training curriculum for diabetes and endocrinology issued by the Joint Royal Colleges of Physicians Training Board. It is also a great opportunity for more established clinicians to find out the latest updates in the area of diabetes.

ABCD has been working with the In-Patient Diabetes lead for Diabetes UK, Prof Gerry Rayman, and a group of Specialists in Diabetes to produce much needed guidance describing the maintenance and delivery of specialist diabetes services during COVID-19.

The document is intended for those involved in delivering and redesigning diabetes services in the light of this pandemic. It recognises the importance of maintaining certain elements of the diabetes service which will be essential in reducing the burden on hospitals and supporting inpatient teams.

At the recent EASD in Vienna, there were three presentations from the ABCD audit programme. 

In a short oral presentation, Dr Alex Liarakos presented data showing that in the ABCD NHS England pilot audit of hybrid closed loop therapy (HCL) which was launched in 2021, that achieving glycaemic targets with HCL therapy in adults with type 1 diabetes is associated with lower levels of diabetes distress.

This webinar will provide healthcare professionals a clinical update on screening for type 1 diabetes.

Presented at EASD 61th Annual Meeting, Vienna, September 2025

R.E.J. Ryder¹, R. Drummond², B. McGowan³, S. Amiel⁴, R. Lopez-Gonzalez⁵, J. Pujol⁵, H. Frydenberg⁶, J. Stein⁷, T. Battelino⁸, S. Fishman⁹, C. de Jonge¹⁰, J. Greve¹¹, R. Cohen¹², M. Yadagiri¹, P. Sen Gupta³;

A UK realworld data from Association of British Clinical Diabetologists national audit

Presented at EASD 61th Annual Meeting, Vienna, September 2025

K. Su Khin ¹ , T. Crabtree ² , A. Liarakos 1 , W. Ahmad ³ , A. Maliekal ³ , V. Oguntolu ⁴ , A. Gough ⁵ , S. Krishnasamy ⁶ , H. Reid ⁷ , K. Adamson ⁷ , G.R. Mudiyanselage ⁵ , E. Wilmot ⁸ , I. Idris ⁹ , R.E.J. Ryder ¹⁰ 

Presented at EASD 61th Annual Meeting, Vienna, September 2025

Alexandros L. Liarakos^1,2, Thomas S.J. Crabtree¹, Tomás P. Griffin^3,4, Sufyan Hussain^5,6,7, Jackie Elliott^8,9, Mark L Evans^10,11, Robert E.J. Ryder¹⁴, Pratik Choudhary^3,4, Emma G. Wilmot^1,2